Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 2c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Infleqtion (INFQ) call put ratio 19 calls to 1 put with a focus on July 30 and August 20 calls as share price up 13.2%
• Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns